{
    "clinical_study": {
        "@rank": "99059", 
        "acronym": "MBI/US", 
        "brief_summary": {
            "textblock": "A combined molecular breast imaging / ultrasound system will enable coregistration of a\n      functional abnormality seen on Molecular Breast Imaging (MBI) with the corresponding\n      anatomical abnormality seen on ultrasound."
        }, 
        "brief_title": "Pilot Study: Combined Molecular Breast Imaging/Ultrasound System for Diagnostic Evaluation of MBI-detected Lesions", 
        "condition": "Breast Cancer", 
        "condition_browse": {
            "mesh_term": "Breast Neoplasms"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  The pilot study will comprise 12 women age 40 and older who have at least one of the\n             following inclusion criteria:\n\n               1. Have a finding of a mass lesion on mammography or breast MRI (BIRADS 0, 4 or 5)\n                  that is >0.5 cm and < 2 cm in size and has had or will have additional workup\n                  with focused ultrasound.\n\n               2. Have a finding of a mass lesion on ultrasound (BIRADS 0, 4 or 5) that is > 0.5\n                  cm and < 2 cm in size.\n\n               3. Have a positive finding on MBI that is < 2 cm in size and requires additional\n                  diagnostic workup with focused ultrasound.\n\n        Exclusion Criteria:\n\n          1. Are unable to understand and sign the consent form\n\n          2. Are pregnant or lactating\n\n          3. Are physically unable to sit upright and still for 40 minutes\n\n          4. Have undergone bilateral mastectomy\n\n          5. Are not scheduled to undergo conventional ultrasound"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "40 Years"
        }, 
        "enrollment": {
            "#text": "12", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 1, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01806558", 
            "org_study_id": "12-004900"
        }, 
        "intervention": {
            "description": "Molecular breast Imaging is a new nuclear medicine technique for imaging the breast. It uses small filed of view semiconductor-based gamma cameras that use Cadmium Zinc Telluride detectors. These have superior spatial and energy resolution to conventional sodium iodide detectors.", 
            "intervention_name": "Molecular Breast Imaging", 
            "intervention_type": "Procedure", 
            "other_name": "MBI"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Breast cancer", 
            "molecular breast imaging", 
            "breast", 
            "breast lesion"
        ], 
        "lastchanged_date": "September 6, 2013", 
        "link": {
            "description": "Mayo Clinic You Tube Channel", 
            "url": "http://www.youtube.com/watch?v=DOQBLe8MdH0"
        }, 
        "location": {
            "facility": {
                "address": {
                    "city": "Rochester", 
                    "country": "United States", 
                    "state": "Minnesota", 
                    "zip": "55905"
                }, 
                "name": "Mayo Clinic"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Pilot Study: Combined Molecular Breast Imaging/Ultrasound System for Diagnostic Evaluation of MBI-detected Lesions", 
        "overall_official": {
            "affiliation": "Mayo Clinic", 
            "last_name": "Michael K O'Connor, PhD, R-D", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Presence / absence of correlation between lesion seen on ultrasound and lesion seen on MBI.", 
            "measure": "To evaluate the potential benefits of co-registered MBI and ultrasonic information relative to independent acquisition of each modality.", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01806558"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Mayo Clinic", 
            "investigator_full_name": "Michael O'Connor", 
            "investigator_title": "PI", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "results_reference": {
            "PMID": "21045179", 
            "citation": "Rhodes DJ, Hruska CB, Phillips SW, Whaley DH, O'Connor MK. Dedicated dual-head gamma imaging for breast cancer screening in women with mammographically dense breasts. Radiology. 2011 Jan;258(1):106-18. Epub 2010 Nov 2."
        }, 
        "source": "Mayo Clinic", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Mayo Clinic", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Intervention Model: Single Group Assignment, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}